|
US7763609B2
(en)
|
2003-12-15 |
2010-07-27 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
US7700603B2
(en)
|
2003-12-15 |
2010-04-20 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
PE20070135A1
(es)
|
2005-06-14 |
2007-03-09 |
Schering Corp |
Compuestos heterociclicos como inhibidores de aspartil proteasas
|
|
WO2006138265A2
(en)
|
2005-06-14 |
2006-12-28 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors, preparation and use thereof
|
|
CA2628074C
(en)
|
2005-10-25 |
2014-01-14 |
Shionogi & Co., Ltd. |
Aminodihydrothiazine derivative
|
|
PE20080155A1
(es)
|
2006-06-12 |
2008-03-10 |
Schering Corp |
Compuestos heterociclicos como inhibidores de aspartil-proteasa
|
|
US8653067B2
(en)
|
2007-04-24 |
2014-02-18 |
Shionogi & Co., Ltd. |
Pharmaceutical composition for treating Alzheimer's disease
|
|
JP5383484B2
(ja)
|
2007-04-24 |
2014-01-08 |
塩野義製薬株式会社 |
環式基で置換されたアミノジヒドロチアジン誘導体
|
|
PL2233474T3
(pl)
|
2008-01-18 |
2015-12-31 |
Eisai R&D Man Co Ltd |
Skondensowana pochodna aminodihydrotiazyny
|
|
CA2723222C
(en)
|
2008-04-22 |
2013-04-02 |
Schering Corporation |
Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use
|
|
TWI431004B
(zh)
*
|
2008-05-02 |
2014-03-21 |
Lilly Co Eli |
Ｂａｃｅ抑制劑
|
|
KR101324426B1
(ko)
|
2008-06-13 |
2013-10-31 |
시오노기세야쿠 가부시키가이샤 |
β 세크레타제 저해 작용을 갖는 황 함유 복소환 유도체
|
|
CN102105475B
(zh)
*
|
2008-07-28 |
2014-04-09 |
卫材R&D管理有限公司 |
螺氨基二氢噻嗪衍生物
|
|
WO2010021680A2
(en)
|
2008-08-19 |
2010-02-25 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of beta-secretase
|
|
MY148558A
(en)
|
2008-09-11 |
2013-04-30 |
Amgen Inc |
Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use
|
|
JP5666304B2
(ja)
*
|
2008-09-30 |
2015-02-12 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
新規な縮合アミノジヒドロチアジン誘導体
|
|
CN102186841A
(zh)
|
2008-10-22 |
2011-09-14 |
盐野义制药株式会社 |
具有bace1抑制活性的2-氨基嘧啶-4-酮及2-氨基吡啶衍生物
|
|
MX2011009571A
(es)
|
2009-03-13 |
2011-10-19 |
Boehringer Ingelheim Int |
Inhibidores de beta-secretasa.
|
|
GB0912777D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydropyrimidone derivatives
|
|
GB0912778D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydro-oxazine derivatives
|
|
EP2485590B1
(en)
|
2009-10-08 |
2015-01-07 |
Merck Sharp & Dohme Corp. |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
|
WO2011044187A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
EP2485920B1
(en)
|
2009-10-08 |
2016-04-27 |
Merck Sharp & Dohme Corp. |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
|
AU2013234424B9
(en)
*
|
2009-10-08 |
2014-07-03 |
Merck Sharp & Dohme Llc |
Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
|
|
UA108363C2
(uk)
|
2009-10-08 |
2015-04-27 |
|
Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
|
|
JPWO2011070781A1
(ja)
|
2009-12-09 |
2013-04-22 |
塩野義製薬株式会社 |
置換アミノチアジン誘導体
|
|
WO2011071057A1
(ja)
*
|
2009-12-09 |
2011-06-16 |
塩野義製薬株式会社 |
含硫黄複素環誘導体を含有するアルツハイマー症の治療用または予防用医薬組成物
|
|
MX2012006491A
(es)
|
2009-12-11 |
2012-07-03 |
Shionogi & Co |
Derivados de oxazina.
|
|
WO2011077726A1
(ja)
|
2009-12-24 |
2011-06-30 |
塩野義製薬株式会社 |
４－アミノ－１，３－チアジンまたはオキサジン誘導体
|
|
JP5828848B2
(ja)
|
2010-02-24 |
2015-12-09 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
ベータセクレターゼインヒビター
|
|
US8497264B2
(en)
|
2010-03-15 |
2013-07-30 |
Amgen Inc. |
Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
|
|
EP2547685A1
(en)
|
2010-03-15 |
2013-01-23 |
Amgen Inc. |
Spiro-tetracyclic ring compounds as beta - secretase modulators
|
|
MX339640B
(es)
|
2010-06-09 |
2016-06-01 |
Janssen Pharmaceutica Nv * |
Derivados de 5, 6-dihidro-2h-[1, 4] oxazin-3-il-amina utiles como inhibidores de la beta-secretasa (bace).
|
|
MX2012014382A
(es)
*
|
2010-06-09 |
2013-01-29 |
Janssen Pharmaceutica Nv |
Derivados de 5-amino-3, 6-dihidro-1h-pirazin-2-ona utiles como inhibidores de beta-secretasa (bace).
|
|
US8921363B2
(en)
|
2010-08-05 |
2014-12-30 |
Amgen Inc. |
Derivatives of 1 H-isoindol-3-amine, 1 H-iso-aza-indol-3amine, 3,4-dihydroisoquinolin-1-amine, and 1,4-dihydroisoquinolin-3-amine as beta-secretase inhibitors
|
|
EP2634188A4
(en)
|
2010-10-29 |
2014-05-07 |
Shionogi & Co |
FUSIONED AMINODIHYDROPYRIMIDINE DERIVATIVE
|
|
JP5816630B2
(ja)
|
2010-10-29 |
2015-11-18 |
塩野義製薬株式会社 |
ナフチリジン誘導体
|
|
US8957083B2
(en)
|
2010-11-23 |
2015-02-17 |
Amgen Inc. |
Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use
|
|
EP2655376B1
(en)
|
2010-12-22 |
2017-08-23 |
Janssen Pharmaceutica NV |
5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
|
|
GB201100181D0
(en)
|
2011-01-06 |
2011-02-23 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
ES2624288T3
(es)
|
2011-01-21 |
2017-07-13 |
Eisai R&D Management Co., Ltd. |
Métodos y compuestos útiles en la síntesis de derivados de aminodihidrotiazina condensados
|
|
GB201101140D0
(en)
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
GB201101139D0
(en)
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
US9346827B2
(en)
|
2011-02-07 |
2016-05-24 |
Amgen Inc. |
5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use
|
|
EP2675810A1
(en)
|
2011-02-15 |
2013-12-25 |
Amgen Inc. |
Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use
|
|
CN103415519B
(zh)
|
2011-03-01 |
2016-03-02 |
詹森药业有限公司 |
作为β-分泌酶(BACE)抑制剂有用的6，7-二氢-吡唑[1，5-a]吡嗪-4-基胺衍生物
|
|
AU2012224632B2
(en)
|
2011-03-09 |
2016-06-16 |
Janssen Pharmaceutica Nv |
3,4-dihydro-pyrrolo[1,2-a]pyrazin-1-ylamine derivatives useful as inhibitors of beta-secretase (BACE)
|
|
EP2694521B1
(en)
|
2011-04-07 |
2015-11-25 |
Merck Sharp & Dohme Corp. |
Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
EP2694489B1
(en)
|
2011-04-07 |
2017-09-06 |
Merck Sharp & Dohme Corp. |
C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
CN103596939A
(zh)
*
|
2011-04-13 |
2014-02-19 |
默沙东公司 |
作为bace抑制剂的5-取代的亚氨基噻嗪类及其单和二氧化物、组合物及其应用
|
|
BR112013026341A2
(pt)
|
2011-04-13 |
2019-09-24 |
Merck Sharp & Dohe Corp |
composto, composição farmacêutica, e, método para tratar, prevenir e/ou atrasar o início de uma doença ou patologia
|
|
US20140235626A1
(en)
|
2011-04-26 |
2014-08-21 |
Shionogi & Co., Ltd. |
Pyridine derivatives and a pharmaceutical composition for inhibiting bace1 containing them
|
|
US8883779B2
(en)
|
2011-04-26 |
2014-11-11 |
Shinogi & Co., Ltd. |
Oxazine derivatives and a pharmaceutical composition for inhibiting BACE1 containing them
|
|
CN103874496A
(zh)
|
2011-08-22 |
2014-06-18 |
默沙东公司 |
作为bace抑制剂的2-螺-取代的亚氨基噻嗪类及其单和二氧化物、组合物及其用途
|
|
WO2013044092A1
(en)
|
2011-09-21 |
2013-03-28 |
Amgen Inc. |
Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
|
|
TWI557112B
(zh)
|
2012-03-05 |
2016-11-11 |
百靈佳殷格翰國際股份有限公司 |
β－分泌酶抑制劑
|
|
TW201422592A
(zh)
|
2012-08-27 |
2014-06-16 |
Boehringer Ingelheim Int |
β－分泌酶抑制劑
|
|
JP2015532282A
(ja)
|
2012-09-28 |
2015-11-09 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
β−セクレターゼの阻害剤
|
|
WO2014059185A1
(en)
|
2012-10-12 |
2014-04-17 |
Amgen Inc. |
Amino - dihydrothiazine and amino - dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
|
|
EP2908824B1
(en)
|
2012-10-17 |
2018-05-02 |
Merck Sharp & Dohme Corp. |
Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
US9422277B2
(en)
|
2012-10-17 |
2016-08-23 |
Merck Sharp & Dohme Corp. |
Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use
|
|
EP2912035A4
(en)
|
2012-10-24 |
2016-06-15 |
Shionogi & Co |
DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY
|
|
WO2014078314A1
(en)
|
2012-11-15 |
2014-05-22 |
Amgen Inc. |
Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
|
|
CA2899938C
(en)
|
2013-02-12 |
2021-10-19 |
Buck Institute For Research On Aging |
Hydantoins that modulate bace-mediated app processing
|
|
WO2014134341A1
(en)
|
2013-03-01 |
2014-09-04 |
Amgen Inc. |
Perfluorinated 5,6-dihydro-4h-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
MX374512B
(es)
|
2013-03-08 |
2025-03-06 |
Amgen Inc |
Compuestos de 1,3-oxazin-2-amina fusionados con ciclopropilo perfluorado como inhibidores de beta-secretasa y métodos de uso.
|
|
TWI593692B
(zh)
*
|
2013-03-12 |
2017-08-01 |
美國禮來大藥廠 |
四氫吡咯并噻嗪化合物
|
|
MX368326B
(es)
|
2013-06-12 |
2019-09-27 |
Janssen Pharmaceutica Nv |
Derivados de 4-amino-6-fenil-5,6-dihidroimidazo[1,5-a]pirazin-3(2h )-ona como inhibidores de beta-secretasa (bace).
|
|
KR102243134B1
(ko)
|
2013-06-12 |
2021-04-22 |
얀센 파마슈티카 엔.브이. |
베타-세크레타제(bace) 저해제로서의 4-아미노-6-페닐-5,6-디하이드로이미다조[1,5-a]피라진 유도체
|
|
BR112015030597A2
(pt)
|
2013-06-12 |
2017-07-25 |
Janssen Pharmaceutica Nv |
derivados 4-amino-6-fenil-6,7-di-hidro[1,2,3]triazolo[1,5-a]pirazina como inibidores de beta-secretase (bace)
|
|
JO3318B1
(ar)
*
|
2013-06-18 |
2019-03-13 |
Lilly Co Eli |
مثبطات bace
|
|
WO2015017407A1
(en)
|
2013-07-30 |
2015-02-05 |
Amgen Inc. |
Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta- secretase
|
|
KR20160115936A
(ko)
*
|
2014-02-19 |
2016-10-06 |
하. 룬드벡 아크티에셀스카브 |
알츠하이머병의 치료를 위한 bace1 저해제로서의 2-아미노-3,5,5-트리플루오로-3,4,5,6-테트라하이드로피리딘
|
|
CN106795147B
(zh)
|
2014-08-08 |
2020-09-22 |
美国安进公司 |
作为β-分泌酶抑制剂的环丙基稠合噻嗪-2-胺化合物和使用方法
|
|
ES2768823T3
(es)
|
2014-12-18 |
2020-06-23 |
Janssen Pharmaceutica Nv |
Derivados de 2,3,4,5-tetrahidropiridin-6-amina y 3,4-dihidro-2H-pirrol-5-amina útiles como inhibidores de beta-secretasa
|
|
WO2016149057A1
(en)
*
|
2015-03-19 |
2016-09-22 |
Eli Lilly And Company |
Selective bace1 inhibitors
|
|
WO2017024180A1
(en)
|
2015-08-06 |
2017-02-09 |
Amgen Inc. |
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
WO2017061534A1
(en)
|
2015-10-08 |
2017-04-13 |
Shionogi & Co., Ltd. |
Dihydrothiazine derivatives
|
|
US20210355138A1
(en)
*
|
2016-08-11 |
2021-11-18 |
Eli Lilly And Company |
Aminothiazinies and their use as bace1 inhibitors
|
|
CA3047288A1
(en)
|
2016-12-15 |
2018-06-21 |
Amgen Inc. |
Thiazine derivatives as beta-secretase inhibitors and methods of use
|
|
EP3555085B1
(en)
|
2016-12-15 |
2020-12-02 |
Amgen Inc. |
Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
|
|
MX394391B
(es)
|
2016-12-15 |
2025-03-24 |
Amgen Inc |
Derivados de tiazina y oxazina biciclicos como inhibidores de beta-secretasa y metodos de uso.
|
|
CA3047290A1
(en)
|
2016-12-15 |
2018-06-21 |
Amgen Inc. |
1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use
|
|
AU2017376441B2
(en)
|
2016-12-15 |
2021-10-14 |
Amgen Inc. |
Oxazine derivatives as beta-secretase inhibitors and methods of use
|
|
TWI654978B
(zh)
*
|
2017-01-27 |
2019-04-01 |
美商美國禮來大藥廠 |
5－甲基－1,2,4－二唑－3－基化合物
|
|
AU2019258575A1
(en)
|
2018-04-27 |
2020-10-29 |
Shionogi & Co., Ltd. |
Tetrahydropyranooxazine derivatives having selective BACE1 inhibitory activity
|